Abstract

Although Krüppel-associated box domain-containing zinc-finger proteins (K-ZNFs) may be associated with sophisticated gene regulation in higher organisms, the physiological functions of most K-ZNFs remain unknown. The Zfp212 protein was highly conserved in mammals and abundant in the brain; it was mainly expressed in the cerebellum (Cb). Zfp212 (mouse homolog of human ZNF212) knockout (Zfp212-KO) mice showed a reduction in survival rate compared to wild-type mice after 20 months of age. GABAergic Purkinje cell degeneration in the Cb and aberrant locomotion were observed in adult Zfp212-KO mice. To identify genes related to the ataxia-like phenotype of Zfp212-KO mice, 39 ataxia-associated genes in the Cb were monitored. Substantial alterations in the expression of ataxin 10, protein phosphatase 2 regulatory subunit beta, protein kinase C gamma, and phospholipase D3 (Pld3) were observed. Among them, Pld3 alone was tightly regulated by Flag-tagged ZNF212 overexpression or Zfp212 knockdown in the HT22 cell line. The Cyclic Amplification and Selection of Targets assay identified the TATTTC sequence as a recognition motif of ZNF212, and these motifs occurred in both human and mouse PLD3 gene promoters. Adeno-associated virus-mediated introduction of human ZNF212 into the Cb of 3-week-old Zfp212-KO mice prevented Purkinje cell death and motor behavioral deficits. We confirmed the reduction of Zfp212 and Pld3 in the Cb of an alcohol-induced cerebellar degeneration mouse model, suggesting that the ZNF212–PLD3 relationship is important for Purkinje cell survival.

Details

Title
Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation
Author
Khang Rin 1 ; Areum, Jo 1 ; Kang Hojin 1 ; Kim, Hanna 1 ; Kwag Eunsang 1 ; Ji-Yeong, Lee 1 ; Koo Okjae 2 ; Park Jinsu 3 ; Kim, Hark Kyun 3 ; Dong-Gyu, Jo 4 ; Hwang Inwoo 5 ; Jee-Yin, Ahn 6 ; Lee, Yunjong 7 ; Jeong-Yun, Choi 7 ; Yun-Song, Lee 7 ; Joo-Ho, Shin 8 

 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University School of Medicine, Laboratory Animal Research Center, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); ToolGen, Seoul, South Korea (GRID:grid.410909.5) 
 Sungkyunkwan University, School of Pharmacy, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University, School of Pharmacy, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University, Biomedical Institute for Convergence, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X) 
 Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613) 
 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613) 
 Sungkyunkwan University School of Medicine, Department of Pharmacology, Samsung Biomedical Research Institute, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Sungkyunkwan University School of Medicine, Single Cell Network Research Center, Suwon, South Korea (GRID:grid.264381.a) (ISNI:0000 0001 2181 989X); Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, South Korea (GRID:grid.414964.a) (ISNI:0000 0001 0640 5613) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2601151476
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.